Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole Monotherapy in Acute Bipolar I Mania
NCT00095511Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Jun 2004
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aripiprazole in bipolar I disorder (3 arms), sponsored by Otsuka Pharmaceutical Development & Commercialization. Primary endpoint: Young Mania Rating Scale at 3 weeks. Started Jun 2004; status: completed.
02
Drugs
aripiprazole
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00095511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095511.